Targeted Codelivery of Doxorubicin and Carvacrol Nanogels
In this study, nanogels were developed using thiolated hyaluronic acid (HASH) and vinyl sulfonated β-cyclodextrin (CDVS) via a water-in-oil emulsion
Tag: hyaluronic acid
On-off switch of cellular migration using granular hydrogels containing beta-CD and adamantane
Cell migration plays a crucial role in the dynamic processes that guide tissue development, regeneration, and repair; yet, developing cell
Shear-thinning hydrogel for allograft cell transplantation and externally controlled transgene expression
This work establishes the design of a fully synthetic, shear-thinning hydrogel platform that is injectable and can isolate engineered, allogeneic
Stabilized, ROS-sensitive β-cyclodextrin-grafted hyaluronic supramolecular nanocontainers for CD44-targeted anticancer drug delivery
Hyaluronic acid (HA)-based tumor microenvironment-responsive nanocontainers are attractive candidates for anticancer drug delivery due to HA’s excellent biocompatibility, biodegradability, and
CD-based diagnostic tool for atherosclerotic plaque
Atherosclerosis (AS), a pathological cause of cardiovascular disease, results from endothelial injury, local progressive inflammation, and excessive lipid accumulation. AS
Nanomedicine-based drug delivery strategies for the treatment of atherosclerosis
This review provides a comprehensive overview of emerging nanomedicine-based strategies for targeted delivery of anti-atherosclerosis drugs, elucidating their distinct mechanisms
Hyaluronic Acid-Based Injective Medical Devices: In Vitro Characterization of Novel Formulations Containing Biofermentative Unsulfated Chondroitin or Extractive Sulfated One with Cyclodextrins
Currently, chondroitin sulfate (CS) and hyaluronic acid (HA) pharma-grade forms are used for osteoarthritis (OA) management, CS as an oral
Hyaluronic acid-cyclodextrin conjugate encapsulating paeonol for treatment of atopic dermatitis
CD was grafted onto hyaluronic acid (HA) to form a topical delivery carrier (HACD) in which Paeonol was loaded in
DOLATROX®hcc
DOLATROX®hcc is the first medical device of Kolinpharma SPA launched in January 2021. It is a pre-filled syringe based on hyaluronic
Polarization of Stem Cells Directed by Magnetic Field-Manipulated Supramolecular Polymeric Nanofibers
Precise assembly of the cytoskeleton (e.g., actin, tubulin, and intermediate filaments) is of great importance for stem cell polarization and